38 results on '"Seaman, Michael"'
Search Results
2. A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption
3. Structure of the membrane proximal external region of HIV-1 envelope glycoprotein
4. First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
5. Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike
6. Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV
7. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
8. Writing in the Secondary Foreign Language Classroom: The Effects of Prompts and Tasks on Novice Learners of French
9. Structural basis for membrane anchoring of HIV-1 envelope spike
10. HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
11. λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies
12. Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
13. HIV-1 neutralizing antibodies induced by native-like envelope trimers
14. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein
15. Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans
16. Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex
17. First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002)
18. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
19. Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1
20. Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial
21. Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
22. First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
23. Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding
24. A Comparison of the Exact Kruskal-Wallis Distribution to Asymptotic Approximations for All Sample Sizes up to 105
25. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
26. A mouse model for HIV-1 entry
27. HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
28. Enhanced HIV-1 neutralization by antibody heteroligation
29. Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
30. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
31. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
32. Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent (Menge with Dryvax
33. Safety and Immunogenidty of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration
34. ECONOMICAL PCR-GENERATED DNA LADDER FOR AGAROSE GELS
35. Persistent Low-Level Viremia in HIV-1 Elite Controllers and Relationship to Immunologic Parameters
36. Vocal Evidence of Toddler Music Syntax Acquisition: A Case Study
37. Exact Small-Sample Differential Item Functioning Methods for Polytomous Items with Illustration Based on an Attitude Survey
38. The Effect of Time Constraints and Statistics Test Anxiety on Test Performance in a Statistics Course
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.